Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-09-22

FDA Approved: LONSURF — Original Application (Taiho Pharmaceutical Co., Ltd.)

View source ↗

Summary

The FDA approved LONSURF (trifluridine and tipiracil) under an original application from Taiho Pharmaceutical Co., Ltd. for metastatic colorectal cancer after p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lonsurf (trifluridine/tipiracil)

Snippet

ORIG AP for LONSURF (TRIFLURIDINE AND TIPIRACIL)